Abstract
Objective
The main objective is to compare the oncologic outcomes of patients with T3 laryngeal cancers who underwent total laryngectomy or organ preservation protocol (OPP) as the initial plan of management.
Materials and methods
This is a retrospective study on 120 patients treated for T3 laryngeal and hypopharyngeal cancers. Patients with functional larynx underwent OPP and dysfunctional larynx underwent upfront laryngectomy. Median follow-up of the patients was 4.6 years.
Results
There was a significant difference in 3 year disease-free survival (DFS) between upfront laryngectomy and OPP (73.2 vs. 55.7%; P = 0.028) group but not in 3 year overall survival (73.2 vs. 68.7%, P = 0.8). The rate laryngeal preservation was 65% in CCRT and 44% in only radiotherapy group. At 3 years, the laryngectomy-free survival was 57.2% and the laryngo-esophageal dysfunction-free survival (LEDS) was 53.0%.
Conclusion
T3 laryngeal cancers treated with upfront laryngectomy have an improved DFS when compared to those treated with non-surgical modalities. Primary surgery should be offered as an option for selected patients especially when CCRT is not feasible.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00405-018-5047-8/MediaObjects/405_2018_5047_Fig1_HTML.gif)
Similar content being viewed by others
References
Group* TD of VALCS (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685–1690
Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098
Rieger JM, Zalmanowitz JG, Wolfaardt JF (2006) Functional outcomes after organ preservation treatment in head and neck cancer: a critical review of the literature. Int J Oral Maxillofac Surg 35:581–587
Staton J, Robbins KT, Newman L, Samant S, Sebelik M, Vieira F (2002) Factors predictive of poor functional outcome after chemoradiation for advanced laryngeal cancer. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg 127:43–47
Dias FL, Lima RA, Kligerman J, Cernea CR (2005) Therapeutic options in advanced laryngeal cancer: an overview. ORL 67:311–318
Lefebvre J-L, Ang KK (2009) Larynx preservation clinical trial design: key issues and recommendations—a consensus panel summary. Int J Radiat Oncol 73:1293–1303
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, New York
Posner MR, Norris CM, Wirth LJ, Shin DM, Cullen KJ, Winquist EW et al (2009) Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol 20:921–927
Lefebvre J-L, Andry G, Chevalier D, Luboinski B, Collette L, Traissac L et al (2012) Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891. Ann Oncol 23:2708–2714
Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890–899
Forastiere AA, Zhang Q, Weber RS, Maor MH, Goepfert H, Pajak TF, Morrison W et al (2013) Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 31(7):845–852. https://doi.org/10.1200/JCO.2012.43.6097
Gorphe P, Matias M, Even C, Ferte C, Bidault F, Garcia G et al (2016) Laryngo-esophageal dysfunction-free survival in a preservation protocol for T3 laryngeal squamous-cell carcinoma. Anticancer Res 36(12):6625–6630
Taguchi T, Nishimura G, Takahashi M, Komatsu M, Sano D, Sakuma N et al (2013) Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy. Cancer Chemother Pharmacol 72:837–843
Chen AY, Halpern M (2007) Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 133:1270–1276
Hoffman HT, Porter K, Karnell LH et al (2006) Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 116(9 Pt 2 Suppl 111):1–13
Al-Gilani M, Skillington SA, Kallogjeri D, Haughey B, Piccirillo JF (2016) Surgical vs nonsurgical treatment modalities for T3 glottic squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 142(10):940–946
Dziegielewski PT, O’Connell DA, Klein M, Fung C, Singh P, Alex Mlynarek M et al (2012) Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival. J Otolaryngol Head Neck Surg J Otorhinolaryngol Chir Cervicofac 41(Suppl 1):S56–S64
Harris BN, Biron VL, Donald P, Farwell DG, Luu QC, Bewley AF et al (2015) Primary surgery vs chemoradiation treatment of advanced-stage hypopharyngeal squamous cell carcinoma. JAMA Otolaryngol Neck Surg 141:636–640
Timmermans AJ, de Gooijer CJ, Hamming–Vrieze O, Hilgers FJ, van den Brekel MW (2015) T3-T4 laryngeal cancer in The Netherlands Cancer Institute; 10-year results of the consistent application of an organ-preserving/-sacrificing protocol. Head Neck 37:1495–1503. https://doi.org/10.1002/hed.23789
Machtay M, Moughan J, Trotti A et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26(21):3582–3589. https://doi.org/10.1200/JCO.2007.14.8841
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Nair, S.V., Mair, M., Sawarkar, N. et al. Organ preservation vs primary surgery in the management of T3 laryngeal and hypopharyngeal cancers. Eur Arch Otorhinolaryngol 275, 2311–2316 (2018). https://doi.org/10.1007/s00405-018-5047-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-018-5047-8